Mesothelioma | Mesothelioma news | Breaking lung cancer news | Mesothelioma | Mesothelioma

Genentech "outperform," estimates raised

...The EPS estimate for FY06 has been raised by $0.04.

Genentech Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using Standard&Poor's ComStock Inc.

and others.

Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.

All content copyright newratings.com.

All rights reserved.

Republication or redistribution strictly prohibited without the prior written consent of newratings.com.

In no event shall newratings.com be held liable for this or any other content, or for any actions taken in reliance thereon.

newratings.com makes no warranties, either express or implied, as to the fitness of the content for any particular purpose.

...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Lung Cancer   Best Cancer Care   Breast Cancer